Neoadjuvant therapy in resectable non-stage IV non-small cell lung cancer: real-world analysis

被引：0
|
作者：
Ay, L. [1 ,2 ]
Fabikan, H. [1 ]
Steiner, D. [3 ]
Illini, O. [1 ,2 ]
Krenbek, D. [4 ]
Klikovits, T. [5 ]
Lang-Stoeberl, A. [1 ]
Mueser, N. [1 ,6 ]
Kirchbacher, K. [1 ,6 ]
Funk, G. C. [1 ,6 ]
Watzka, S. [5 ]
Valipour, A. [1 ,2 ]
Hochmair, M. [1 ,2 ]
机构：
[1] Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria
[2] Klin Floridsdorf, Vienna Healthcare Grp, Dept Resp & Crit Care Med, Vienna, Austria
[3] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria
[4] Klin Floridsdorf, Vienna Healthcare Grp, Dept Pathol, Vienna, Austria
[5] Klin Floridsdorf, Vienna Healthcare Grp, Dept Thorac Surg, Vienna, Austria
[6] Klin Ottakring, Vienna Healthcare Grp, Dept Internal Med Pulmonol 2, Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2024年 / 136卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P25
引用
收藏
页码：S533 / S533
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [32] An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
    Qi, Yuwen
    Gu, Linping
    Shen, Jie
    Yao, Yaxian
    Zhao, Yi
    Lu, Shun
    Chen, Zhiwei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Establishment and validation of a survival prediction model for stage IV non-small cell lung cancer: a real-world study
    Zheng, Keao
    Zhang, Junyan
    Xu, Tingting
    Li, Fangyu
    Li, Feng
    Zeng, Jing
    Guo, Yimeng
    Hao, Zhiying
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [34] Genomic alterations of bone metastases in stage IV non-small cell lung cancer (NSCLC) and real-world outcomes
    Voon, P. J.
    Riely, G. J.
    Lepisto, E. M.
    Lavery, J. A.
    Warner, J. L.
    LeNoue-Newton, M. L.
    Sweeney, S. M.
    McCarthy, C. G.
    Samantha, B.
    Panageas, K. S.
    Weiss, J.
    Yu, C.
    Sacher, A.
    Kehl, K. L.
    Leighl, N.
    Schrag, D.
    Bedard, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S992 - S992
  • [35] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [36] Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
    Faltermeier, Claire M.
    Lee, Jay M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) : 4328 - 4335
  • [37] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Broderick, Stephen R.
    Bott, Matthew J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05): : 1471 - 1474
  • [38] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [39] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [40] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)
12345